Latest News by Industry
PARSIPPANY, N.J.--(BUSINESS WIRE)--Sep 29, 2022--
Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, Nov. 3, 2022. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Wetteny Joseph will review third quarter 2022 financial results and respond to questions from financial analysts during the call.
About Zoetis
As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After 70 years innovating ways to predict, prevent, detect, and treat animal illness, Zoetis continues to stand by those raising and caring for animals worldwide - from livestock farmers to veterinarians and pet owners. The company’s leading portfolio and pipeline of medicines, vaccines, diagnostics, and technologies make a difference in over 100 countries. A Fortune 500 company, Zoetis generated revenue of $7.8 billion in 2021 with approximately 12,100 employees. For more, visit www.zoetis.com.
ZTS-COR
ZTS-IR
View source version on businesswire.com:https://www.businesswire.com/news/home/20220927006100/en/
CONTACT: Media:
Bill Price
1-973-443-2742 (o)
william.price@zoetis.comKristen Seely
1-973-443-2777 (o)
kristen.seely@zoetis.comInvestors:
Steve Frank
1-973-822-7141 (o)
steve.frank@zoetis.comNick Soonthornchai
1-973-443-2792 (o)
nick.soonthornchai@zoetis.com
KEYWORD: UNITED STATES NORTH AMERICA NEW JERSEY
INDUSTRY KEYWORD: HEALTH HEALTH TECHNOLOGY OTHER HEALTH PHARMACEUTICAL VETERINARY BIOTECHNOLOGY
SOURCE: Zoetis Inc.
Copyright Business Wire 2022.
PUB: 09/29/2022 09:26 AM/DISC: 09/29/2022 09:26 AM
http://www.businesswire.com/news/home/20220927006100/en